FdaApplication
NDA 215039
Identifiers
- fda_app_no: NDA215039
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2022-04-05 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VIJOICE | ALPELISIB | 125MG | TABLET;ORAL |
| VIJOICE | ALPELISIB | 200MG | TABLET;ORAL |
| VIJOICE | ALPELISIB | 50MG | TABLET;ORAL |
3 products